ImmunityBio, Inc. IBRX Operating Lease Liability - Undiscounted Excess Amount
Operating Lease Liability - Undiscounted Excess Amount at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s operating lease liability - undiscounted excess amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s operating lease liability - undiscounted excess amount?
- ImmunityBio, Inc. (IBRX) reported operating lease liability - undiscounted excess amount of $10.5M in Q1 2026.
- How has ImmunityBio, Inc.'s operating lease liability - undiscounted excess amount changed year-over-year?
- ImmunityBio, Inc.'s operating lease liability - undiscounted excess amount decreased by 13.4% year-over-year, from $12.12M to $10.5M.